The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.
Market Growth Overview
- Current Size and Growth Rate:
- The high flow needle sets market was valued at $1.07 billion in 2023.
- It is projected to grow to $1.16 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.3%.
- The growth is driven by advancements in medical procedures, chronic disease prevalence, demographic shifts, and healthcare infrastructure improvements.
- Future Projections:
- By 2028, the market is expected to reach $1.67 billion.
- This represents a CAGR of 9.4% during the forecast period.
- Key growth factors include medical procedure modernization, increasing minimally invasive surgeries, and expanding global healthcare access.
View More On The High Flow Needle Sets Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/high-flow-needle-sets-global-market-report
Impact of Rising Surgical Procedures
- Growth Driver:
- The increasing number of surgical procedures is a significant factor driving market growth.
- Surgeons perform these procedures to diagnose, treat, or repair tissues and organs, aiming to enhance patient health.
- Contributing Factors:
- An aging population, technological advancements, chronic disease prevalence, and improved access to healthcare contribute to the rise in surgeries.
- High-flow needle sets are crucial for rapid fluid, medication, or blood product administration during surgeries.
- Example:
- A report from the Aesthetic Society noted a 54% increase in surgical procedures in 2021, highlighting the growing demand for high-flow needle sets.
Major Companies in the Market
- Key Players:
- Cardinal Health Inc.
- Thermo Fisher Scientific Inc.
- Fresenius Medical Care AG & Co. KGaA
- Becton Dickinson and Company
- Baxter International Inc.
- Others:
- Medline Industries Inc., Terumo Corporation, Nipro Corporation, and more.
Innovations in High Flow Needle Sets
- Portable Syringe Infusion Systems:
- Companies are developing portable systems to enhance patient mobility and ease of use.
- Example: Koru Medical Systems’ FreedomEdge Syringe Infusion System, approved in October 2021, offers controlled, subcutaneous administration with flexible dosing schedules.
- Technological Developments:
- Innovations include advancements in infusion technology and integration with digital health solutions.
Strategic Acquisitions
- ICU Medical and Smiths Medical:
- In January 2022, ICU Medical acquired Smiths Medical, expanding its product line to include high flow intravenous administration sets and needles.
- This acquisition enhances ICU Medical’s capabilities in infusion therapy and vascular access.
Market Segmentation
- By Product Type:
- 26 Gauge High Flow Needle Sets
- 24 Gauge High Flow Needle Sets
- By Volume/Capacity:
- Less than 10 ml
- Between 10-100 ml
- Greater than 100 ml
- By Material:
- Stainless Steel
- Polycarbonate
- By End Use:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Other End-Users
Regional Insights
- Current Market Leader:
- North America was the largest market region in 2023.
- Future Growth Region:
- Asia-Pacific is expected to be the fastest-growing region during the forecast period.
The high flow needle sets market is set for continued robust growth driven by increasing surgical procedures, technological advancements, and strategic industry expansions.
Request A Sample Of The Global High Flow Needle Sets Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15821&type=smp